$CSN (-0,06 %) Would you say it's worth getting in right now, or would you wait for a pullback?

Chesnara $CSN (-0,06 %) In my view, Chesnara presented very solid financial results today. It is particularly encouraging that the growth following the acquisitions is also clearly reflected in cash generation.

Key points:

- Dividend up 6% to 8.16 pence per share. Chesnara is thus continuing its long-standing progressive dividend policy.

- Operating capital generation: £96 million, up from £54 million in the same period last year—an increase of 79%.

- Cash remittances: £73 million, also significantly higher than last year (+31%).

- Adjusted operating profit: £31 million, compared to £21 million in the same period last year.

- Assets under administration: £21 billion, up from £15 billion.

- Solvency II ratio: 185%. Following the major acquisition of Chesnara Life, a significant decline in the previously very high ratio had been expected. The 185% figure is even higher than the company’s own forecast of 180% and remains comfortably above the operating target range of 140–160%.

- Own funds rose from £859 million to £976 million.

- Central available liquidity stands at £271 million.

- Leverage is only 19% and thus remains moderate despite the acquisitions.

The integration of Chesnara Life UK also appears to be proceeding according to plan so far. The new unit has already contributed £51 million in operating capital generation and £20 million in cash remittance. According to management, the planned migration remains on schedule.

At the same time, the acquisition of Scottish Widows Europe is moving forward. The regulatory review is underway, the readiness tests have been completed, and the transaction is still expected to close around the end of 2026. Even after that, Chesnara anticipates a solvency ratio above its own target range.

Conclusion: Overall, I consider these to be very strong figures. I am particularly pleased with the combination of a 79% increase in capital generation, rising cash flows, continued high solvency, and another 6% dividend increase. Despite the major acquisitions, the balance sheet remains solid, and the dividend payout continues to appear well-supported based on current capital generation. The key now will be to ensure that the integration of the acquired portfolios continues to be executed smoothly.

@Dividendenopi I’m sure you’re thrilled about that 😬

Hey there, fellow investors! 🚀

Last night, I once again had an in-depth discussion with my trusty AI companion about our stocks, and together we did a bit of market research.

(It’s a new version of Mr. Prompt—more on the Prompt update, including the automatic market screener, coming in early September.)

We were specifically looking for a few very special stocks to add a crisis-proof, rock-solid cash generator to our portfolio.

As we pored over the key metrics and looked beyond the big tech hype, we stumbled upon a British stock that nearly made our eyes pop out of our heads.

The crazy thing is:

This absolute dividend gem is still flying completely under the radar here in the forum—and, in fact, among almost all retail investors!

I think for our dividend collectors like @Dividendenopi
@PoorDad or @Keineui this is a great stock.

But @Multibagger I promise you, there’s a great stock coming your way later this week that fits your investment style :)

Only 5 analysts have even rated this stock so far.

Grab a coffee and sit back. Here’s our comprehensive 15-point overview of one of the most exciting and consistent cash generators—one that no income portfolio should be without. Curtain up for Chesnara!🔥

$CSN (-0,06 %)

1. What does the company do?

Chesnara plc is a highly profitable acquirer and manager of life insurance and pension portfolios.

The business model is ingeniously simple: The company purchases so-called “closed books” (insurance portfolios that no longer accept new customers) from other insurers and manages them extremely cost-effectively until maturity. This enables Chesnara to generate highly predictable and steady cash flows.

2. Geographic Presence & Brand Portfolio

Chesnara operates primarily in three core markets:

the United Kingdom, the Netherlands, and Sweden. The company has recently expanded its footprint significantly: In January 2026, it completed the acquisition of HSBC Life (UK) for £260 million (approx. €304 million).

In addition, the acquisition of the Luxembourg-based Scottish Widows Europe SA for €110 million was announced in February 2026, marking the company’s entry into the Luxembourg market.

3. Key Figures, Data & Facts (as of August 2026)

• Current share price: 340.00 GBX (pence) or £3.40 (approx. 3.98 €).
• Market capitalization: £787 million (approx. €921 million) – A true mid-cap.
• P/E Ratio (Trailing): 15.15x.
• Dividend yield: 6.62%.
• Tax Highlight: In the United Kingdom, dividends are subject to 0% withholding tax! This means that the gross dividend is paid out to us in full (aside from the domestic flat-rate withholding tax) without any annoying foreign withholding taxes.
• Solvency II Ratio: 257%—a staggering figure that far exceeds the target range of 140% to 160%.
• Assets under Administration (AuA): £15 billion (approx. €17.5 billion). On a pro forma basis following the latest acquisitions, this figure is even on track to reach £20 billion (approx. €23.4 billion).

4. Check against our established formulas

• Core Quality Formula: For an insurance consolidator, the classic industry margin doesn’t apply perfectly. Nevertheless, adjusted operating profit (AOP) recently rose by a whopping 42% to £56 million (approx. €65.5 million).

• Cash Flow Quality Formula (The Cash Engine): Insurers measure their “free cash flow” as “Operating Capital Generation” (OCG). Chesnara generated £94 million (approx. €110 million) here. When viewed in relation to the market capitalization of £787 million (approx. €921 million), this results in an sensational OCG yield of 11.9%! This blows our >8% threshold out of the water.

• Dividend Filter: At 6.62%, the yield is well above our 3.5% minimum. The absolute highlight: Chesnara has increased its dividend in 2025 for the 21st consecutive time ! The payout is absolutely secure, backed by £94 million (approx. €110 million) in OCG and £58 million (approx. €68 million) in operating cash flows. No pseudo-payout funded by debt!

5. Chart Analysis of Recent Months

• Price trend: The stock has posted an extremely strong performance over the past 12 months, rising by over +22%.
• Moving averages: The stock is currently trading about +10.45% above the key 200-day moving average.
• Momentum: Chesnara is currently significantly outperforming the broad UK FTSE All-Share Index. The trend remains intact, and the stock is being steadily accumulated.

6. Special Entry Zones (“Bargain Hunter’s List”)

• Bargain Zone (Absolute Bargain): £2.80 – £3.00 (approx. €3.28 – €3.51). This is where the stock was trading prior to the announcement of the major acquisitions.

• Fair-Value Entry: £3.25 – £3.40 (approx. €3.80 – €3.98). Current level, ideal for building a long-term dividend position.

• Sell/Take partial profits: From £3.80 – £4.00 (approx. €4.45 – €4.68).

7. Risk Deep Dive 1: Acquisition & Integration Risks

With the acquisition of HSBC Life (UK), Chesnara has pulled off the biggest deal in the company’s history. This brings in £5 billion (approx. 5.85 billion €) in new assets and 450,000 new policies.

The risk here lies in IT and administrative migration. When such mega-integrations hit a snag, they eat into margins and management capacity in the short term.

8. Risk Deep Dive 2: The Interest Rate and Capital Markets Environment

As a manager of £15 billion (approx. €17.5 billion) in assets, Chesnara is dependent on global equity and bond markets. Significant volatility in the financial markets or extreme changes in interest rates can cause fluctuations in the “own funds” (equity capital under Solvency II).

For us as euro investors, currency risk (GBP to EUR) is also a factor here.

9. Future Outlook & Growth Drivers

The company operates in a high-growth market.

Many major insurers (such as $HSBA (-0,01 %) or $LLOY (-0,08 %) ) want to offload their old, unprofitable legacy portfolios. Chesnara $CSN (-0,06 %) stands ready with deep pockets.

Thanks to the successful placement of a £150 million (approx. €175 million) RT1 bond last year, management has tremendous financial firepower to acquire additional lucrative portfolios at favorable prices.

10. Competition & Alternative Candidates

• Phoenix Group ($PHNX): The British market leader in this segment. Phoenix is significantly larger but also has higher debt.

• M&G plc ($MNG): Also a strong British dividend stock in the financial sector. By comparison, however, Chesnara is the more agile, specialized player with the more solid balance sheet coverage.

11. Margin & Profitability Analysis

Chesnara’s solvency ratio (Solvency II) rose last year from 203% to a staggering 257% . Eligible capital (“Own Funds”) rose by 34% to £859 million (approx. €1.00 billion).

The company is literally awash in excess capital, which provides massive security for future dividends and M&A activities.

12. Analyst Opinions & Fair Value

• Consensus: The majority of analysts recommend buying Chesnara.
• Price Target: The average analyst price target is 362.80 GBX (£3.63 / approx. €4.25).
• Upside: Based on the current price, this corresponds to a purely theoretical price potential of just under +6.7%— plus the hefty dividend yield!

13. Upcoming Catalysts

The most important milestone in the near future is the so-called “Part VII Transfer” of the newly acquired HSBC Life (UK) portfolios, which is expected in 2027. If this goes smoothly, massive administrative synergies will be realized. In addition, the official completion of the Scottish Widows Europe acquisition is scheduled for late 2026.

14. SEO & Market Sentiment

As a British mid-cap, Chesnara flies completely under the radar among retail investors. There is hardly any media hype or retail focus on the stock.

It is precisely this information asymmetry that works in our favor as patient investors: While the masses chase after expensive tech stocks, Chesnara is quietly acquiring highly profitable insurance portfolios.

15. Long-Term Viability & My Personal Conclusion

Dear Community, if you’re looking for a fundamentally extremely strong, crisis-resistant anchor for your portfolio, Chesnara $CSN (-0,06 %) .

The company delivers a OCG yield of just under 12%, an unshakable solvency ratio of 257% and boasts 21 years of uninterrupted dividend growth .

All of this is sweetened by 0% withholding tax , in my opinion, currently makes Chesnara one of the best and most fairly valued cash generators.

A real gem for reducing volatility in your portfolio and keeping the cash flow steadily flowing!

Greetings from Denmark

Raketentoni

@Keineui

@Aktienhauptmeister

@Multibagger

@Tenbagger2024

@Get_Rich_or_Die_Tryin

@Stocktective

@Simpson

@WarrenamBuffet

@SAUgut777

@TradingHase

@PikaPika0105

@Derspekulant1

@NichtRelevant

@Klein-Anleger

@Dividendenopi

and, of course, everyone else :)